Objectives-To review efficacy and safety of endovascular stent implants in children < 1 year of age with congenital heart lesions. Design-Retrospective study of patients in a tertiary care setting. (Br Heart J 1995;74:689-695) 
Abstract
Objectives-To review efficacy and safety of endovascular stent implants in children < 1 year of age with congenital heart lesions. Design-Retrospective study of patients in a tertiary care setting. Patients-26 children (median age of 47 months, range 2 days to 1 year) with various vascular obstructive lesions. Intervention-Percutaneous or intraoperative implantation of balloon expandable endovascular stents. Results-Optimal stent placement was obtained in 31 of the 37 deployed implants. Complications resulted primarily from stent malpositioning and one episode of bleeding at a puncture site. Stent implantation in three patients with a restrictive arterial duct allowed for patency and five patients with conduit stenosis had mean (SD) right ventricule to systemic artery pressure ratios falling from 0 99 (0.20) to 0 52 (0.18) (P < 0.05). In 10 patients with pulmonary artery stenosis, the mean vessel diameter increased from 2-8 (0.9) mm to 5 8 (1.4) mm (P << 0.001). No clinical improvement was seen in two patients because of diffuse hypoplasia of the pulmonary vessels. Nine of 10 patients with miscellaneous obstructive lesions improved clinically. Recatheterisation was performed in 19 patients (median 8 Endovascular stent implants have been used in various obstructive lesions in childhood, including peripheral pulmonary artery stenosis, systemic or pulmonary venous obstructions, postoperative conduit stenosis, the restrictive arterial duct, and coarctation of the aorta."-3 The effectiveness of such endovascular implants in management of congenital heart lesions has generally been satisfactory and intermediate follow up has been promising, although restenosis has been encountered.3 4 However, most studies have addressed applications in older children. In this regard, infants not infrequently require surgical reintervention or therapeutic catheterisation to address complex cardiac lesions. Because the vessels are smaller, there have been concerns that stent placement in younger children may be difficult, and more complications may occur than noted in older populations. To this end, no studies have specifically addressed whether stent implants can be used safely and effectively, or can improve patient management, in patients of less than 1 year of age.
The purpose of this study was: (1) to evaluate the feasibility, safety, and clinical impact of stent implantation in children < 1 year of age, and (2) to assess the possibility of stent redilatation within the growing patient.
Methods

PATIENTS
Between November 1989 and April 1994, 26 patients < 1 year of age had endovascular stent implantation at the Hospital for Sick Children, Toronto. Parental informed consent was obtained in each patient. There were 1 1 males and 15 females (median age 4-7 months, range 2 days to 1 year, including seven neonates and median weight 5-3 kg, range 2-2 to 9 5 kg). Twenty patients had undergone previous surgery (median 4 0 months, range 1 day to 11 months) between surgery and stent implantation. Cardiac diagnoses of congenital heart disease are listed in table 1. 
DEFINITIONS
Placement was considered successful when the stent was appropriately positioned and expanded at the target site. Implantation was clinically successful if there was a period of improvement when the following conditions were met: (1) disappearance or improvement in symptoms; (2) avoiding or postponing surgical repair; (3) making inoperable circumstances, operable. Haemodynamic or angiographic success was arbitrarily defined as an increase in pulmonary artery size of 50% or more in diameter, or a 20% decrease in right ventricle to systemic artery peak systolic pressure ratio.67 In the situation of conduit stenosis, success was defined when this ratio was reduced to < 50%. Angiographic assessment at follow up catheterisation of intimal proliferation (growth within the stent lumen) was graded as none, mild, moderate, or severe. STATISTICAL 
ANALYSIS
Normally distributed values are expressed as mean (SD). A paired, two tailed t test was used to compare measurements before and after procedure. A P value < 0 05 was considered statistically significant.
Results
OUTCOMES
Clinical profiles of the patients are presented in table 2. A balloon angioplasty before stent implantation was performed in 16 patients (19 procedures) using low pressure balloons (tolerant to 8 atmospheres). In 21 patients (84%), a stent was placed percutaneously, while in five patients (10 stents) an intraoperative approach was used. Vascular access was obtained through the internal jugular vein in five patients, the remainder through the femoral vessels. Catheterisation time ranged from 55 to 210 min and mean fluoroscopy time was 36 (range 11 to 86) minutes.
Placement success was attained in 31 of the 37 deployed stents (84%). Of these deployed stents, a single implant was performed in 19 patients, two implants in four, three implants in two, and four stents in one. In 21 patients (81%), stent implantation resulted in an improved clinical course: nine patients (43%) had symptomatic improvement, nine (43%) avoided or delayed surgical intervention, and three (14%) went on to total correction. Among patient categories, clinical success rate of the procedures was 67% in the restrictive arterial duct, 60% in conduit stenosis, 60% in pulmonary artery stenosis, and 80% in miscellaneous stenotic vessels. SPECIFIC 
LESIONS
The arterial duct Three patients with ductal dependent pulmonary (n = 1) or systemic (n = 2) blood flows had implants to prevent ductal closure. Balloon angioplasty, including high pressure balloons, was previously unsuccessful, with recoil of the vessel. After stent placement, there was symptom relief and collateral venous flow into the azygos vein disappeared.
In one patient with stenosis of an anomalous pulmonary vein draining to the inferior vena cava with scimitar syndrome, a stent was placed at the junction between the pulmonary vein and inferior caval vein with reduction in pulmonary congestion. Another patient developed bilateral pulmonary vein stenosis four months after repair of total anomalous pulmonary venous drainage, and had intraoperative stent implantation with clinical improvement.
One patient with a restrictive atrial septal defect in the setting of double inlet left ventricle had failed balloon atrial septostomy. Attempted stent implantation to maintain atrial defect diameter by straddling the atria (using an hourglass profile) was not successful because of balloon rupture. The stent was positioned in the superior vena cava and removed the following day at surgery.
COMPLICATIONS
Complications during implantation occured in seven patients, including stent malpositions (n = 5), balloon rupture (n = 1), and bleeding at a puncture site (n = 1). In one patient with conduit stenosis, a deployed stent obstructed the right pulmonary artery blood flow by distorting the ostium of the right pulmonary artery (fig 1) . A second patient had a stent positioned just distal to the stenotic lesion in the ductal origin of a left pulmonary artery. Thrombosis of the arterial duct and left pulmonary artery during catheter manipulation resolved with thromolytic therapy, and a central shunt was performed later that day. In a third patient, implantation was first undertaken for left pulmonary artery stenosis, but because of balloon rupture the stent slipped proximally into the right pulmonary artery and was inflated in place. This stent was retieved one month later at surgery. Two stents protruded into aorta or innominate artery in two patients with aortopulmonary shunt (GoreTex) stenosis. Neither obstructed shunt flow or produced thrombus. Balloon rupture in the patient with a restrictive atrial septal defect was mentioned earlier. The patient who bled at a puncture site did not require transfusion.
FOLLOW UP
Twenty one patients (81%) have been followed from 24 days to 36 months (median 12 months). No stent has fractured, migrated, or thrombosed. There were 10 patients whose implanted stents were removed or modified at subsequent surgery without technical difficulties, three within one week of implantation (one in each group). The indications for removal were suboptimal placement in six patients, and in four patients, advancement to the next stage of surgical management where the stent was unnecessary. No thrombus was detected in any removed stent. Of these 10 patients, three had the stent modified by cutting longitudinally and augmenting the circumference with a patch (fig 2) .
Six patients died in this series. There were two early deaths, one during the implant procedure, and another eight days after implantation after pulmonary artery banding (both in the arterial duct group). The four remaining patients died during follow up after further surgical palliation or attempted repair, unrelated to the stent.
RECATHETERISATION AND REDILATATION
Thirty repeat catheterisations were performed in 19 patients (73%) with a median period of eight months (range 12 days to 28 months) after implantation. There were no side branch stenoses in the group with pulmonary artery implants. Of the two patients with stenotic pulmonary veins, one (with scimitar syndrome) developed total occlusion of the stent noted at the 11 months follow up, but remained asymptomatic. Another patient (with postoperative total anomalous pulmonary venous drainage) developed restenosis of all the implants and required a second intraoperative redilatation of the veins with additional stent placement at four months and 2-3 years after implantation.
Eleven patients (42%) had redilatation of 17 stents (14 procedures) within a median 10 months (range three to 22 months) after implantation. Redilatation was attempted because of restenosis of the stent associated with clinical symptoms, or the necessity for improvement in peripheral pulmonary artery flow to encourage growth with small distal pulmonary arteries. Of the 11 patients, a successful haemodynamic response was attained each in three of four conduits, one of six pulmonary artery stenoses, and one cavopulmonary artery stenosis, (table 2, patient 24 had redilatation at different stenotic sites). An attempt to dilate the stent in the patient with total anomalous pulmonary venous drainage was unsuccessful. In responders, intimal proliferation was absent in one patient, mild in three, and moderate in one. In non-responders, intimal proliferation was absent in three patients, moderate in one, and severe in three, but distal vessel hypoplasia was a prominent feature in five patients (fig 2) . In those with conduit stenosis (three responders), the right ventricle to systemic artery peak systolic pressure ratio decreased from 0-64 (0 04) to 0 43 (0-02) (P < 0-005).
Discussion
This review supports previously reported experiences in older children, that endovascular stent implantation is safe and effective acutely in a variety of stenotic lesions, even when used in children less than 1 Restenosis of the stent is one of greatest concern in follow up. O'Laughlin et a14 reported only one patient (of 58) with haemodynamic or angiographic evidence of restenosis, although most of the stents had some degree of intimal proliferation. In our study, significant restenosis with severe intimal proliferation was found in three patients. While recent reports indicate that stent redilatation is possible without adverse effects,416 our data show that the patients most likely to respond were those whose intimal overgrowth was absent or only of a mild degree. Additionally noted was that most non-responders had associated diffuse hypoplasia of the distal pulmonary vessels, regardless of the degree of intimal proliferation. This may have resulted from either an intrinsic abnormality within the pulmonary tree or a secondary effect upon growth of the implanted stent. While acutely relieving the obstruction, rapid intimal proliferation may reduce ipsilateral pulmonary blood flow and result in a hypoplastic vessel distal to the stent. This may produce further patient compromise and limit of the effectiveness of the technique.
In conclusion, we suggest from this experience that stent implantation is technically feasible for infants with a variety of obstructive vascular lesions and provides acute clinical improvement. It can be used as an alternative to surgical palliation or to avoid reoperation. Redilatation of the implant is possible for restenosis; however, in the setting of diffuse hypoplasia of the pulmonary arteries, the improvement is minimal. Long term effects of such small stents may, however, be ultimately detrimental.
A 12 year old boy presented with pulmonary oedema and severe hypertension and was found to be in end stage renal failure. The echocardiogram showed a dilated but well contracting left ventricle with mild hypertrophy. He 
